PAG
GH icon

Private Advisory Group’s Guardant Health GH Stock Holding History

Private Advisory Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,153
Closed -$475K – 224
2025
Q1 		$475K Buy
+11,153
New +$481K 0.05% 146

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Private Advisory Group's GH Position: Q2 2025 in Review

Private Advisory Group sold out of Guardant Health (GH) in Q2 2025, closing a stake of 11,153 shares — an estimated $475K sold.

Private Advisory Group first reported a position in GH in Q1 2025 and held it in 1 quarter. The position peaked at $475K in Q1 2025. 365 funds tracked by Wall St. Rank hold GH as of Q2 2025.

  • Private Advisory Group reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
  • Private Advisory Group sold 11,153 Guardant Health shares in Q2 2025, an estimated $475K.
  • Private Advisory Group first reported a position in Guardant Health in Q1 2025 and held it in 1 quarter.
  • Private Advisory Group's Guardant Health position peaked at $475K in Q1 2025.
  • 365 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Private Advisory Group's 13F filing for Q2 2025, filed 7 Aug 2025.